Gut bacteria may explain differences in peanut allergy reactions
One of the big mysteries in food allergy is why two people with similar levels of peanut specific…
Scientists Just Found a Way to Destroy Deadly Superbugs by Targeting Hidden Sugar
The rise of drug-resistant bacteria is complicating care in hospitals around the world. Among the most feared are…
New technique synthesizes non-natural amino acids for advanced peptide therapeutics
Ozempic has been making headlines for its remarkable success in treating obesity and diabetes. Yet it is just…
Nasal COVID vaccine boost increases IgA responses linked to variant neutralisation
A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering…
Antibody feedback reshapes B cell selection during immune response
A collaborative study published in Immunity from the Batista Lab and Liu Lab at the Ragon Institute, together…
Large Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth rates
Large real-world Swedish data provide reassurance that COVID-19 vaccination does not reduce childbirth rates, helping counter persistent misinformation…
Targeted fab fragments dismantle the allergy trigger
Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe conditions such…
Epigenetic plasticity in germinal center B cells may help explain lymphoma origins
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During…
Using sound waves to soften tumors and boost chemotherapy
Cancer is one of the leading causes of death in the U.S., second only to heart disease. But…
Early RSV infection turns maternal allergy into a powerful driver of childhood asthma
By combining nationwide health data with elegant immunology experiments, researchers reveal how RSV infection in infancy hijacks maternal…
Gene variant linked to higher risk of chronic rejection after lung transplant
About one third of lung transplant recipients have a genetic variant that makes them more likely to develop…
Breakthrough in FcγRI inhibition opens path to safer autoimmune therapies
An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that specifically block…